<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, such as low-grade follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo>/small lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, can transform to histiocytic/dendritic cell <z:hpo ids='HP_0100242'>sarcoma</z:hpo> (H/DS) in rare cases </plain></SENT>
<SENT sid="1" pm="."><plain>The diagnosis of this unconventional neoplastic evolution relies on a combination of immunophenotypic analysis and genotypic studies </plain></SENT>
<SENT sid="2" pm="."><plain>A genotype identical to that of the primary B-cell <z:hpo ids='HP_0002664'>neoplasm</z:hpo> in a secondary <z:hpo ids='HP_0002664'>neoplasm</z:hpo> with H/DS immunophenotype supports the lineage conversion to H/DS </plain></SENT>
<SENT sid="3" pm="."><plain>Putative mechanisms for this unusual phenomenon include <z:e sem="disease" ids="C0002793" disease_type="Neoplastic Process" abbrv="">dedifferentiation</z:e>, common immature progenitor, and <z:mpath ids='MPATH_85'>transdifferentiation</z:mpath> models, the latter of which is suggested by clinical laboratory data at the present time </plain></SENT>
<SENT sid="4" pm="."><plain>Elucidation of the molecular mechanisms governing this lineage conversion may facilitate the understanding of <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> of not only hematopoietic but also nonhematolymphoid <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The clinical outcome of secondary H/DS is dismal, as observed in <z:hpo ids='HP_0003745'>sporadic</z:hpo> cases, and the optimal treatment remains to be determined </plain></SENT>
</text></document>